Fundraising FoxFoundersX Ventures — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
1910 develops an AI platform that integrates multimodal data, frontier AI models, and high-throughput lab automation to accelerate drug discovery and development for pharmaceutical companies.
AI & Machine LearningBiotechDeep TechHealthtechBoston, US
Jen Asher(CEO)inJennifer O. Nwankwo(Executive Officer, Director)Jen Asher, Ph.D.(Founder)inJen Nwankwo(Founder)
BoardSamir Kumar(Director)Marc Foster(Director)
Co-investorsPlayground GlobalY CombinatorEmles Venture PartnersJude GomilaM12 (Microsoft's Venture Fund)Point Reyes Management+5 more
Houm is a proptech platform that helps property owners list and rent residential properties in Latin America.
MarketplacesPropTechSantiago, CL
Benjamín Labra(Founder)inNicolas Knockaert(Founder)inBenjamin Ignacio Labra Zelaya(Executive Officer, Director)Benjamin Labra(Founder)inIan Lee(Founding Software Engineer)Juan Pablo Zepeda(Head of Operations)in
Co-investorsCapria VenturesCathexis VenturesCM VenturesEmles Venture PartnersMagma PartnersMyelin VC+25 more
Zafrens develops a unified drug discovery platform that integrates isolation, imaging, and sequencing workflows to accelerate the identification of therapeutic compounds across modalities.
AI & Machine LearningBiotechDeep TechSan Diego, US
Martin SmrcinainMaina NdunguinSwamy Vijayan(Executive Officer, Director)inYi ZhanginVikas Goelin
BoardJustin Briggsin
Co-investorsAcequia Capital (AceCap)BlueYard CapitalGlobal BrainHAWKTAILIaso Venturesimec.xpand+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.